BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON(BRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BRNS BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON

盘前交易 03-03 08:14:03 EST

0.6118

+0.0277

+4.74%

最高0.6380	最低0.5617	成交量1.99万
今开0.6380	昨收0.5841	日振幅13.06%
总市值2,498万	流通市值2,183万	总股本4,083万
成交额1.19万	换手率0.06%	流通股本3,568万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BRNS","market":"US","secType":"STK","nameCN":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON","latestPrice":0.6118,"timestamp":1772485200000,"preClose":0.5841,"halted":0,"volume":19924,"delay":0,"changeRate":0.047423386406437354,"floatShares":35677165,"shares":40830353,"eps":-1.880153,"marketStatus":"盘前交易","change":0.0277,"latestTime":"03-03 08:14:03 EST","open":0.638,"high":0.638,"low":0.561701,"amount":11905.23753,"amplitude":0.130627,"askPrice":0.6947,"askSize":100,"bidPrice":0.5122,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.880153,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772548200000},"marketStatusCode":1,"adr":0,"adrRate":1,"listingDate":1619755200000,"exchange":"NASDAQ","adjPreClose":0.6118,"postHourTrading":{"tag":"盘后","latestPrice":0.6118,"preClose":0.6118,"latestTime":"19:04 EST","volume":2,"amount":1.2056,"timestamp":1772496258245,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3726368390883317},"requestUrl":"/m/hq/s/BRNS","defaultTab":"news","newsList":[{"id":"2616727317","title":"Barinthus Biotherapeutics Plc盘中异动 早盘股价大涨9.23%报0.638美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616727317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616727317?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:36","pubTimestamp":1772462165,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日22时36分，Barinthus Biotherapeutics Plc股票出现异动，股价快速上涨9.23%。截至发稿，该股报0.638美元/股，成交量1012股，换手率0.00%，振幅0.00%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体跌幅为0.04%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302223609a4429029&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302223609a4429029&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BRNS"],"gpt_icon":0},{"id":"2600170240","title":"Barinthus Biotherapeutics Plc盘中异动 股价大涨5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600170240","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600170240?lang=zh_cn&edition=full","pubTime":"2026-01-01 03:24","pubTimestamp":1767209059,"startTime":"0","endTime":"0","summary":"北京时间2026年01月01日03时24分，Barinthus Biotherapeutics Plc股票出现异动，股价快速拉升5.64%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为0.23%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101032420a6e69a7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101032420a6e69a7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BRNS","BK4139"],"gpt_icon":0},{"id":"2570073134","title":"Barinthus Biotherapeutics Plc盘中异动 早盘急速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570073134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570073134?lang=zh_cn&edition=full","pubTime":"2025-09-25 22:43","pubTimestamp":1758811396,"startTime":"0","endTime":"0","summary":"北京时间2025年09月25日22时43分，Barinthus Biotherapeutics Plc股票出现波动，股价快速下挫5.00%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Scisparc Ltd.、Pepgen Inc.、Evaxion A/S涨幅较大，Scisparc Ltd.、Evaxion A/S、Pepgen Inc.较为活跃，换手率分别为4213.24%、1041.26%、255.24%，振幅较大的相关个股有Scisparc Ltd.、Pepgen Inc.、Leap Therapeutics, Inc.，振幅分别为91.12%、46.99%、28.47%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509252243169544ea99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509252243169544ea99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BRNS"],"gpt_icon":0},{"id":"2517100879","title":"Barinthus Biotherapeutics Plc盘中异动 大幅拉升7.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517100879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517100879?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185063,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Barinthus Biotherapeutics Plc股票出现波动，股价大幅上涨7.53%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为0.08%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223103a260c6ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223103a260c6ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BRNS"],"gpt_icon":0},{"id":"2517660645","title":"Barinthus Biotherapeutics Plc盘中异动 早盘股价大涨8.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517660645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517660645?lang=zh_cn&edition=full","pubTime":"2025-03-05 00:06","pubTimestamp":1741104362,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日00时06分，Barinthus Biotherapeutics Plc股票出现异动，股价急速上涨8.25%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体跌幅为0.36%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305000602a25f1e4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305000602a25f1e4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRNS","BK4139"],"gpt_icon":0},{"id":"2514320426","title":"Barinthus Biotherapeutics Plc盘中异动 早盘急速拉升6.18%报1.030美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320426?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:42","pubTimestamp":1740753756,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时42分，Barinthus Biotherapeutics Plc股票出现异动，股价快速上涨6.18%。截至发稿，该股报1.030美元/股，成交量1120股，换手率0.00%，振幅3.60%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为0.22%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228224236a2580424&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228224236a2580424&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRNS","BK4139","BK4007","VRPX"],"gpt_icon":0},{"id":"2514330836","title":"Barinthus Biotherapeutics Plc盘中异动 临近收盘股价大跌6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514330836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514330836?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:45","pubTimestamp":1740689145,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时45分，Barinthus Biotherapeutics Plc股票出现波动，股价急速下挫6.54%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1947.73%、410.74%、197.27%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280445469895543b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280445469895543b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRNS","BK4139"],"gpt_icon":0},{"id":"2514856311","title":"Barinthus Biotherapeutics Plc盘中异动 急速上涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856311?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:37","pubTimestamp":1740580656,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时37分，Barinthus Biotherapeutics Plc股票出现异动，股价快速拉升5.62%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体跌幅为0.40%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223736abddee7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223736abddee7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BRNS"],"gpt_icon":0},{"id":"2514903060","title":"Barinthus Biotherapeutics Plc股价飙升13.54% 市值涨593.72万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514903060","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514903060?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493877,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Barinthus Biotherapeutics Plc股票出现异动，股价急速上涨13.54%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Organovo Holdings, Inc.、Moleculin Biotech, Inc.、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为747.41%、521.43%、460.59%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Maze Therapeutics, Inc.，振幅分别为32.52%、16.59%、8.87%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223117a2538667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223117a2538667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRNS","BK4139"],"gpt_icon":0},{"id":"2514122775","title":"Barinthus Biotherapeutics Plc盘中异动 早盘股价大跌5.00%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514122775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514122775?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:16","pubTimestamp":1740413769,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时16分，Barinthus Biotherapeutics Plc股票出现异动，股价快速跳水5.00%。截至发稿，该股报0.950美元/股，成交量1.2219万股，换手率0.03%，振幅13.84%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为0.06%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022500160998910dab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022500160998910dab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRNS","BK4139"],"gpt_icon":0},{"id":"2513176792","title":"Barinthus Biotherapeutics Plc盘中异动 临近收盘股价大跌5.21%报1.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513176792","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513176792?lang=zh_cn&edition=full","pubTime":"2025-02-22 05:01","pubTimestamp":1740171698,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日05时01分，Barinthus Biotherapeutics Plc股票出现异动，股价急速跳水5.21%。截至发稿，该股报1.00美元/股，成交量4692股，换手率0.01%，振幅2.98%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为0.32%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222050139988e2de9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222050139988e2de9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BRNS"],"gpt_icon":0},{"id":"2512048870","title":"Barinthus Biotherapeutics Plc盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512048870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512048870?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:32","pubTimestamp":1739975564,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时32分，Barinthus Biotherapeutics Plc股票出现异动，股价大幅拉升5.10%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Osr Holdings, Inc.、Aditxt, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为213.83%、203.50%、65.92%，振幅较大的相关个股有Osr Holdings, Inc.、Azitra Inc、Opthea Limited，振幅分别为34.08%、11.29%、11.01%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192232459628cd7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192232459628cd7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRNS","BK4139"],"gpt_icon":0},{"id":"2512674171","title":"Barinthus Biotherapeutics Plc盘中异动 大幅下跌5.50%报1.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512674171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512674171?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:48","pubTimestamp":1739897339,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时48分，Barinthus Biotherapeutics Plc股票出现异动，股价快速跳水5.50%。截至发稿，该股报1.03美元/股，成交量1.1806万股，换手率0.03%，振幅9.63%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为0.60%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190048599627ae5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190048599627ae5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRNS","BK4139"],"gpt_icon":0},{"id":"2511997266","title":"Barinthus Biotherapeutics Plc盘中异动 早盘股价大涨5.32%报1.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511997266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511997266?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:44","pubTimestamp":1739544284,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时44分，Barinthus Biotherapeutics Plc股票出现波动，股价急速拉升5.32%。截至发稿，该股报1.09美元/股，成交量2369股，换手率0.01%，振幅4.35%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为0.28%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422444496231e79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422444496231e79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRNS","BK4139","BK4007","VRPX"],"gpt_icon":0},{"id":"2511552905","title":"Barinthus Biotherapeutics Plc盘中异动 早盘股价大跌6.22%报0.994美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511552905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511552905?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:07","pubTimestamp":1739459279,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时07分，Barinthus Biotherapeutics Plc股票出现异动，股价快速跳水6.22%。截至发稿，该股报0.994美元/股，成交量1.1366万股，换手率0.03%，振幅7.55%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为0.13%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132307599621c435&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132307599621c435&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRNS","BK4139"],"gpt_icon":0},{"id":"2510486131","title":"Barinthus Biotherapeutics Plc盘中异动 快速拉升5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510486131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510486131?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:35","pubTimestamp":1739201756,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时35分，Barinthus Biotherapeutics Plc股票出现异动，股价快速上涨5.83%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体跌幅为0.04%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210233556988085ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210233556988085ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRNS","OCEA","BK4139"],"gpt_icon":0},{"id":"2509744649","title":"Barinthus Biotherapeutics Plc股价飙升10.00% 市值涨40.63万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509744649?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:33","pubTimestamp":1738938834,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时33分，Barinthus Biotherapeutics Plc股票出现波动，股价大幅拉升10.00%。截至发稿，该股报1.10美元/股，成交量2112股，换手率0.01%，振幅0.00%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体跌幅为0.06%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223354987dade4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223354987dade4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRNS","BK4139"],"gpt_icon":0},{"id":"2509287925","title":"Barinthus Biotherapeutics Plc盘中异动 大幅上涨7.41%报1.060美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509287925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509287925?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:55","pubTimestamp":1738767302,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时55分，Barinthus Biotherapeutics Plc股票出现异动，股价急速拉升7.41%。截至发稿，该股报1.060美元/股，成交量207股，换手率0.00%，振幅0.00%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为1.73%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020522550296190d5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020522550296190d5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","BK4139","BRNS"],"gpt_icon":0},{"id":"2508576894","title":"Barinthus Biotherapeutics Plc盘中异动 股价大涨5.53%报1.050美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508576894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508576894?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:33","pubTimestamp":1738679595,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时33分，Barinthus Biotherapeutics Plc股票出现异动，股价急速上涨5.53%。截至发稿，该股报1.050美元/股，成交量1663股，换手率0.00%，振幅4.02%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体跌幅为0.16%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223315abc2287d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223315abc2287d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BRNS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.barinthusbio.com","stockEarnings":[{"period":"1week","weight":0.0546},{"period":"1month","weight":-0.1619},{"period":"3month","weight":-0.1454},{"period":"6month","weight":-0.5183},{"period":"1year","weight":-0.3943},{"period":"ytd","weight":-0.1261}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0081},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.0662},{"period":"1year","weight":0.1552},{"period":"ytd","weight":0.0065}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Barinthus Biotherapeutics plc于2016年1月根据英格兰和威尔士的法律注册成立。该公司是一家临床阶段的生物制药公司，致力于发现和开发新型T细胞免疫治疗候选药物，旨在引导免疫系统克服慢性传染病、自身免疫和癌症。该公司拥有广泛的临床和临床前阶段治疗和预防项目。该公司目前的治疗方案包括用于治疗慢性乙型肝炎感染的VTP-300，用于治疗人乳头状瘤病毒感染的VTP-200，用于治疗前列腺癌的VTP-850，用于治疗非小细胞肺癌的VTP-600，用于治疗乳糜泻的VTP-1000，以及用于治疗HPV相关癌症的VTP-1100。后两个程序旨在利用SNAPvaxTM平台。该公司目前的预防项目包括用于预防带状疱疹或带状疱疹的VTP-400，以及用于预防中东呼吸综合征或MERS的VTP-500。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.054418},{"month":2,"riseRate":0.2,"avgChangeRate":-0.100765},{"month":3,"riseRate":0.2,"avgChangeRate":-0.120346},{"month":4,"riseRate":0.75,"avgChangeRate":0.019565},{"month":5,"riseRate":0.4,"avgChangeRate":-0.038691},{"month":6,"riseRate":0.4,"avgChangeRate":-0.079301},{"month":7,"riseRate":0.8,"avgChangeRate":0.145921},{"month":8,"riseRate":0.2,"avgChangeRate":-0.115362},{"month":9,"riseRate":0.6,"avgChangeRate":0.076316},{"month":10,"riseRate":0.6,"avgChangeRate":0.081459},{"month":11,"riseRate":0,"avgChangeRate":-0.272926},{"month":12,"riseRate":0.6,"avgChangeRate":0.072478}],"exchange":"NASDAQ","name":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON","nameEN":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON(BRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON(BRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON,BRNS,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票老虎,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票老虎国际,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON行情,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票行情,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股价,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股市,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票价格,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票交易,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票购买,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON(BRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON(BRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}